Trial intelligence / Profile preview

Propofol vs Sevoflurane on CD39/CD73 in Cardiac Surgery

NCT02136979Phase 4Completed

Sponsor
Konkuk University Medical Center
Start
May 2014
Primary completion
Dec 2016
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of propofol, sevoflurane in valvular heart disease (VHD), aortic disease, sponsored by Konkuk University Medical Center. Started May 2014; status: completed.

02

Drugs

propofolsevoflurane
03

Conditions

valvular heart disease (VHD)aortic disease

Beyond the preview

Go deeper on NCT02136979.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02136979.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call